iStock-694432294
print header

Immunization

Herpes Zoster (HZ/Shingles) Vaccine

Zostavax®II (Herpes Zoster Vaccine) protects against the shingles virus.

• This vaccine is only publicly funded (free) for adults aged 65-70 years.
• It is recommended (but not publicly funded) for:

• Adults ≥ 50 years without contraindications - the incidence and severity of Herpes Zoster (HZ) begins to increase with age beyond 50 years.
• Adults with history of HZ disease may have lower recurrence rates following vaccination. For this reason HZ vaccine may be given to those over the age of 50 with a history of HZ disease. Clients should wait at least 1 year between their last episode of shingles, and receiving the vaccine.
• Shingles vaccine should be administered to individuals eligible for the vaccine regardless of whether or not the person has a history of varicella infection. Nearly all Canadians eligible for shingles vaccine will have had prior varicella exposure, even if a diagnosis of varicella cannot be recalled. Therefore, the vaccine should still be offered to individuals to protect against herpes zoster.

• This vaccine significantly reduces the incidence of Hz and PHN (post-herpetic neuralgia) as well as the duration and severity of Hz.
• Research shows that protection following this vaccine remains up to 3 years following immunization.
• At this time there are no other ways to prevent this disease (aside from vaccination). Hand washing and covering the mouth and nose while coughing/sneezing can help reduce the spread of disease.

• There is another shingles vaccine available in Canada, however it is not currently publicly funded (free). Shingrix® is not a live vaccine so it can be given to people who are immunocompromised (from medication or a medical condition). This vaccine costs approximately $150 per dose. 2 doses are required for full protection. For more information about this vaccine, please follow up with your Health Care Provider or local pharmacist.

• The risk of a serious reaction or side effect from this vaccine is much less than the risk of HZ.
• If you experience any side effect worse than what is listed below, please seek medical advice and notify the health unit.

Common

• Pain, swelling and redness where needle was given.
• Fatigue
• Myalgia

Rare

• Anaphylaxis

• Adults with a history of HZ Ophthalmicus should only be immunized in consultation with their ophthalmologist.
• Anyone with an allergy to any of the vaccine components or who has had an allergic or anaphylactic reaction to this vaccine.
• Any immunocompromised person – see health care provider for further recommendations.
• Anyone with blood disorders or cancers affecting the bone marrow, blood or lymphatic system.
• Anyone who is pregnant. Women should delay pregnancy 3 months after receiving this vaccine.
• Anyone with active, untreated tuberculosis (TB).
• Anyone who has had another live vaccine in the last 4 weeks.
• Anyone who has active HZ disease. Clients should wait at least 1 year between an episode of HZ and receiving the HZ vaccine
• Anyone who is suffering from severe acute illness.

Zostavax®II

Also found in…

Neomycin

Antibiotics

Porcine gelatin

Lunch meats, frozen desserts

Bovine calf serum

Antibiotics/Anti-inflammatories

Monosodium L-glutamate

Tomatoes, parmesan cheese

Potassium chloride

Chocolate milk, Yogurt

Potassium phosphate monobasic

Food additive

Sodium chloride

Table salt

Sucrose

Table Sugar

Sodium phosphate dibasic

Laxatives, food additive-emulsifier, leavening agent for baked goods

Click the share button to:

• Tell us about the immunizations your child received
• Get your child’s immunization record

  Immunization Online Logo

Did you find what you were looking for today?
What did you like about this page?
How can we improve this page?
Page
Feedback

If you have any questions or concerns that require a response, please contact Health Connection directly.

Thanks for your feedback.
Failed to submit comment. Please try submitting again or contact us at the Health Unit.
Comment already submitted ...